
Vendor diversification on containerized missiles mirrors the ATACMS strategy: establish multiple production sources to hedge against single-point failure and create downward price pressure through competition. If CoAspire, Leidos, and Zone 5 are each ramping production, the Pentagon is signaling it expects sustained demand through the 2030s — not a spike that drops off.
That demand signal matters to the industrial base: smaller primes like CoAspire and Zone 5 now have guaranteed volume to justify capital investment in manufacturing capacity. Leidos, as a systems integrator, likely plays a different role — possibly in integration, testing, or containerization architecture rather than warhead/motor production.
This is production confirmation, not a surprise.
The Army already locked in 10,000+ Barracuda-500M units from Anduril alone in a three-year deal (announced May 15). Now the Pentagon is diversifying the supply base across four vendors instead of concentrating risk on a single prime.
That means Anduril's Barracuda contract coexists with parallel production lines at CoAspire, Leidos, and Zone 5 — each presumably building different containerized missile variants or the same platform under license. The framework structure suggests the Pentagon is betting on sustained demand at scale: framework agreements are scaffolding for multi-year, multi-tranche buys, not one-off procurements.
Watch the Q3 2026 contract modifications to see whether the Pentagon splits the 10,000+ total evenly across four vendors or front-loads Anduril (which already has production momentum) while ramping the others.
Does the 10,000+ total include Anduril's Barracuda contract, or is this an additional 10,000 across the other three vendors? The C4ISRNET article doesn't specify, and it matters for capacity planning.
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.